CO5300464A1 - Metodo para regular la angiogenesis utilizando proteina ryk - Google Patents
Metodo para regular la angiogenesis utilizando proteina rykInfo
- Publication number
- CO5300464A1 CO5300464A1 CO01036462A CO01036462A CO5300464A1 CO 5300464 A1 CO5300464 A1 CO 5300464A1 CO 01036462 A CO01036462 A CO 01036462A CO 01036462 A CO01036462 A CO 01036462A CO 5300464 A1 CO5300464 A1 CO 5300464A1
- Authority
- CO
- Colombia
- Prior art keywords
- sec
- protein
- ryk
- variant
- site
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title abstract 3
- 230000001105 regulatory effect Effects 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 3
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56878300A | 2000-05-10 | 2000-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5300464A1 true CO5300464A1 (es) | 2003-07-31 |
Family
ID=24272718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO01036462A CO5300464A1 (es) | 2000-05-10 | 2001-05-09 | Metodo para regular la angiogenesis utilizando proteina ryk |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1287121A2 (https=) |
| JP (1) | JP2004527206A (https=) |
| AR (1) | AR028424A1 (https=) |
| AU (1) | AU2001261343A1 (https=) |
| CA (1) | CA2408349A1 (https=) |
| CO (1) | CO5300464A1 (https=) |
| DO (1) | DOP2001000164A (https=) |
| EC (1) | ECSP014068A (https=) |
| GT (1) | GT200100079A (https=) |
| PE (1) | PE20011218A1 (https=) |
| SV (1) | SV2002000442A (https=) |
| UY (1) | UY26696A1 (https=) |
| WO (1) | WO2001085789A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1471934A2 (en) * | 2002-02-06 | 2004-11-03 | DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung | Kinases involved in the regulation of energy homeostasis |
| JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
| KR102486321B1 (ko) | 2014-07-18 | 2023-01-09 | 사노피 | 암을 앓고 있는 것으로 의심되는 환자를 아플리베르셉트로 치료한 결과를 예측하는 방법 |
| CA3229528A1 (en) * | 2021-08-18 | 2023-02-23 | The Regents Of The University Of California | Anti-related-to-receptor tyrosine kinase (ryk) antibodies and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07506969A (ja) * | 1992-05-11 | 1995-08-03 | ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ | レセプタ型チロシンキナーゼ類似の分子 |
| NZ328371A (en) * | 1994-12-23 | 1999-05-28 | Ludwig Inst Cancer Res | Method of detecting a ligand capable of binding the receptor protein neuroepithelial tyrosine kinase (nyk) and its use in therapeutic compositions |
| AU4278299A (en) * | 1998-06-11 | 1999-12-30 | Astrazeneca Ab | Human receptor tyrosine kinase |
| CA2348835A1 (en) * | 1998-10-28 | 2000-05-04 | Cornell Research Foundation, Inc. | Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
-
2001
- 2001-05-07 GT GT200100079A patent/GT200100079A/es unknown
- 2001-05-07 AR ARP010102149A patent/AR028424A1/es not_active Application Discontinuation
- 2001-05-08 UY UY26696A patent/UY26696A1/es not_active Application Discontinuation
- 2001-05-09 AU AU2001261343A patent/AU2001261343A1/en not_active Abandoned
- 2001-05-09 CA CA002408349A patent/CA2408349A1/en not_active Abandoned
- 2001-05-09 WO PCT/US2001/015043 patent/WO2001085789A2/en not_active Ceased
- 2001-05-09 SV SV2001000442A patent/SV2002000442A/es not_active Application Discontinuation
- 2001-05-09 JP JP2001582388A patent/JP2004527206A/ja active Pending
- 2001-05-09 EC EC2001004068A patent/ECSP014068A/es unknown
- 2001-05-09 CO CO01036462A patent/CO5300464A1/es unknown
- 2001-05-09 EP EP01935233A patent/EP1287121A2/en not_active Withdrawn
- 2001-05-10 DO DO2001000164A patent/DOP2001000164A/es unknown
- 2001-05-10 PE PE2001000417A patent/PE20011218A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DOP2001000164A (es) | 2002-05-15 |
| EP1287121A2 (en) | 2003-03-05 |
| GT200100079A (es) | 2001-12-31 |
| SV2002000442A (es) | 2002-07-03 |
| CA2408349A1 (en) | 2001-11-15 |
| UY26696A1 (es) | 2001-12-28 |
| ECSP014068A (es) | 2002-02-25 |
| JP2004527206A (ja) | 2004-09-09 |
| AU2001261343A1 (en) | 2001-11-20 |
| AR028424A1 (es) | 2003-05-07 |
| WO2001085789A3 (en) | 2002-05-16 |
| WO2001085789A2 (en) | 2001-11-15 |
| PE20011218A1 (es) | 2002-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR021448A1 (es) | Metodo para producir un polipeptido quimerico | |
| AR012531A1 (es) | Composicion para cuidado personal, composicion para repasador y metodo para minimizar o reducir la comezon o quemado de la piel a causa de composicionespara cuidado personal que contienen acido. | |
| ES2183945T3 (es) | Composiciones para mejorar el aporte de un agente por electrotransporte. | |
| ES2194376T3 (es) | Preparacion especifica de sitio de conjugados de polietilenglicol-grf. | |
| PE20110236A1 (es) | Proteccion y mejoramiento de celulas, tejidos y organos que responden a la eritropoyetina | |
| BR9814276A (pt) | Antìgenos de superfìcie | |
| ATE240729T1 (de) | Methoden und zusammensetzungen zur lipidisierung hydrophiler moleküle | |
| NO992068L (no) | Mikroemulsjon og fremgangsmÕte for fremstilling av denne | |
| ATE208612T1 (de) | Biologisch erodierbare vorrichtung zur verabreichung von wirkstoffen | |
| DE50107705D1 (de) | Neue pharmazeutische zusammensetzung zur verabreichung von n-0923 | |
| ES2123910T3 (es) | Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol. | |
| AR023529A1 (es) | Una composicion champu acondicionadora del cabello y un metodo para acondicionar el cabello | |
| BR0108734A (pt) | Composições antimicrobiais ácidas para tratar alimento e superfìcies de contato do alimento e métodos para uso das mesmas | |
| ATE251448T1 (de) | Polyol/öl-suspensionen zur verzörgerten freisetzung von proteinen | |
| ES2141229T3 (es) | Productos farmaceuticos de proteinas y peptidos modificados. | |
| ES2096872T3 (es) | Composiciones limpiadoras acuosas acidas. | |
| TW200518767A (en) | Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins | |
| ES2183332T3 (es) | Aminoacidos biciclicos aromaticos. | |
| AR018357A1 (es) | Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos | |
| DK0953576T3 (da) | Aktivt hedgehog-proteinkonjugat, fremgangsmåde til fremstilling heraf og anvendelse | |
| NO20073914L (no) | Biologisk aktive peptider | |
| CO5570658A2 (es) | Composicion y metodo para el tratamiento de la diabetes | |
| CO5300464A1 (es) | Metodo para regular la angiogenesis utilizando proteina ryk | |
| AR033979A1 (es) | Metodo para preparar un polipeptido il-18 fisiologicamente activo | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall |